LEP and breast carcinoma: The present study aimed to investigate the effects of physiological and supraphysiological levels of leptin (≤1,600 ng/ml) on proliferation in SK-BR-3 and MDA-MB-231 breast cancer cells, two cell lines representative of HER-2-positive and basal-type breast cancer subtypes, respectively.